Hepatocellular carcinoma - Resection or transplant?

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 12, 2012, Pages 732-737

  Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR ABLATION;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84870624025     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.158     Document Type: Review

References (46)

1. International Agency for Research on Cancer. Liver cancer incidence, mortality and prevalence worldwide in 2008 [online], http://globocan.iarc.fr/ factsheet.asp (2012).
2. Roskams, T. & Kojiro, M. Pathology of early hepatocellular carcinoma: Conventional and molecular diagnosis. Semin. Liver Dis. 30, 17-25 (2010).
3. Torimura, T. et al. Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma. Immunohistochemical study. Arch. Pathol. Lab. Med. 115, 365-371 (1991).
4. Kojiro, M. in Pathology of Hepatocellular Carcinoma 31-49 (Blackwell Publishing, Malden, 2006).
5. Zhu, L. X., Wang, G. S. & Fan, S. T. Spontaneous rupture of hepatocellular carcinoma. Br. J. Surg. 83, 602-607 (1996). (Pubitemid 26163544)
6. O'Malley, M. E., Takayama, Y. & Sherman, M. Outcome of small (10-20 mm) arterial phase-Enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. Am. J. Gastroenterol. 100, 1523-1528 (2005). (Pubitemid 41032357)
7. Yang, Z. F., Poon, R. T., To, J., Ho, D. W. & Fan, S. T. The potential role of hypoxia inducible factor 1α in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res. 64, 5496-5503 (2004). (Pubitemid 39006574)
8. Man, K. et al. Molecular signature linked to acute phase injury and tumor invasiveness in small for size liver grafts. Ann. Surg. 251, 1154-1161 (2010).
9. Penn, I. The effect of immunosuppression on pre-Existing cancers. Transplantation 55, 742-747 (1993). (Pubitemid 23122039)
10. Fan, S. T. et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience. Ann. Surg. 253, 745-758 (2011).
11. Kubota, K. et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26, 1176-1181 (1997). (Pubitemid 27509300)
12. Takayama, T. & Makuuchi, M. Preoperative portal vein embolization: Is it useful? J. Hepatobiliary Pancreat. Surg. 11, 17-20 (2004). (Pubitemid 38404327)
13. Gaba, R. C. et al. Radiation lobectomy: Preliminary findings of hepatic volumetric response to lobar yttrium 90 radioembolization. Ann. Surg. Oncol. 16, 1587-1596 (2009).
14. Ishizawa, T. et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134, 1908-1916 (2008). (Pubitemid 351783260)
15. Finkelstein, S. D. et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology 37, 871-879 (2003). (Pubitemid 36397398)
16. Sherman, M. Recurrence of hepatocellular carcinoma. N. Engl. J. Med. 359, 2045-2047 (2008).
17. Fan, S. T. et al. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: A prospective study. Ann. Surg. 254, 569-576 (2011).
18. Okamura, Y. et al. Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J. Surg. Oncol. 104, 814-821 (2011).
19. Hoshida, Y. et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 359, 1995-2004 (2008).
20. Huang, J. et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann. Surg. 252, 903-912 (2010).
21. Mazzaferro, V. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334, 693-699 (1996). (Pubitemid 26079803)
22. Yao, F. Y. Liver transplantation for hepatocellular carcinoma: Beyond the Milan criteria. Am. J. Transplant. 8, 1982-1989 (2008).
23. Zheng, S. S. et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85, 1726-1732 (2008).
24. DuBay, D. et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann. Surg. 253, 166-172 (2011).
25. Lee, S. G. et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl. 14, 935-945 (2008).
26. Chan, S. C., Fan, S. T., Lo, C. M., Liu, C. L. & Wong, J. Toward current standards of donor right hepatectomy for adult to adult live donor liver transplantation through the experience of 200 cases. Ann. Surg. 254, 110-117 (2007). (Pubitemid 46035442)
27. Bhangui, P. et al. Intention to treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation. Hepatology 53, 1570-1579 (2011).
28. Fan, S. T. et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br. J. Surg. 98, 1292-1300 (2011).
29. Lo, C. M. et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br. J. Surg. 94, 78-86 (2007). (Pubitemid 46142736)
30. Fan, S. T. in Living Donor Liver Transplantation, 2nd edn 322 (World Scientific, Singapore, 2011).
31. Chan, S. C. et al. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up to 7 criteria with microvascular invasion. Hepatol. Int. http://dx.doi.org/10.1007/s12072-011-9318-3.
32. Klintmalm, G. B. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome. Ann. Surg. 228, 479-490 (1998). (Pubitemid 30194392)
33. Fung, J. et al. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology 141, 1212-1219 (2011).
34. Doyle, M. B. et al. Liver transplantation for hepatocellular carcinoma: Long-Term results suggest excellent outcomes. J. Am. Coll. Surg. 215, 19-28 (2012).
35. Portolani, N. et al. Limited liver resection: A good indication for the treatment of hepatocellular carcinoma in elderly patients. Jpn J. Clin. Oncol. 41, 1358-1365 (2011).
36. Koniaris, L. G. et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann. Surg. 254, 527-538 (2011).
37. Mazzaferro, V. et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol. 10, 35-43 (2009).
38. Ng, K. K. et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma. Arch. Surg. 143, 68-74 (2008).
39. Majno, P. E., Sarasin, F. P., Mentha, G. & Hadengue, A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-Oriented decision analysis. Hepatology 31, 899-906 (2000). (Pubitemid 30169937)
40. Fuks, D. et al. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention to treat analysis. Hepatology 55, 132-140 (2012).
41. Poon, R. T., Fan, S. T., Lo, C. M., Liu, C. L. & Wong, J. Long-Term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann. Surg. 235, 373-382 (2002). (Pubitemid 34183888)
42. Sala, M. et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation. Liver Transpl. 10, 1294-1300 (2004). (Pubitemid 39406086)
43. Scatton, O. et al. Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantation. Liver Transpl. 14, 779-788 (2008). (Pubitemid 351899426)
44. Landman, M. P., Feurer, I. D., Pinson, C. W. & Moore, D. E. Which is more cost-Effective under the MELD system: Primary liver transplantation, or salvage transplantation after hepatic resection or after loco-Regional therapy for hepatocellular carcinoma within Milan criteria? HPB (Oxford) 13, 783-791 (2011).
45. Ito, T. et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 13, 1637-1644 (2007).
46. Sugawara, Y., Tamura, S. & Makuuchi, M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig. Dis. 25, 310-312 (2007). (Pubitemid 350014958)